Eight reasons GPs aren’t prescribing antivirals for hepatitis C

Only 3% of patients in survey had DAA therapy initiated by a GP

PBS listing of direct acting antivirals (DAAs) for hepatitis C has failed to persuade 95% of GPs to prescribe them, a survey from NSW suggests.


According to a survey of 131 GPs in Sydney, only 5% had prescribed DAA therapy, and only 3% of patients managed by hepatitis treatment clinics had DAA therapy initiated by GPs.

The survey, conducted by gastroenterologists at Sydney’s St George Hospital, found eight major factors in GPs reluctance to prescribe the antivirals that can cure hepatitis C in as little as 12 weeks: